Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Ziegler

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Plos One|March 16, 2017
Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetesDan Ziegler, Karsten Winter, Alexander Strom, et al.
BMJ Open|February 4, 2022
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathyGidon J Bönhof, Gundega Sipola, Alexander Strom, et al.
Clinical Therapeutics|January 26, 2008
Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studiesDaniel K Kajdasz, Smriti Iyengar, Durisala Desaiah, et al.
Diabetes Care|July 22, 2011
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trialDan Ziegler, Phillip A Low, William J Litchy, et al.
Diabetes/Metabolism Research and Reviews|March 27, 2018
Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 studyChristian Herder, Julia M Kannenberg, Cornelia Huth, et al.
Diabetes/Metabolism Research and Reviews|July 4, 2024
Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 studyDan Ziegler, Barbara Thorand, Alexander Strom, et al.
The Journal of Clinical Endocrinology and Metabolism|March 29, 2020
Vitamin B12 and Folate Concentrations in Recent-onset Type 2 Diabetes and the Effect of Metformin TreatmentGeorgia Kanti, Evrim Anadol-Schmitz, Pavel Bobrov, et al.
Diabetes Care|December 8, 2018
General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 CohortSabrina Schlesinger, Christian Herder, Julia M Kannenberg, et al.
Diabetes, Obesity & Metabolism|June 16, 2025
Magnesium and thiamine supplementation increases renal mitochondrial respiration in lean C57BL/6J but not in obese ob/ob miceSebastian Sill, Fariba Zivehe, Carina Heitmann, et al.
Environmental Health Perspectives|December 28, 2020
Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 StudyChristian Herder, Alexandra Schneider, Siqi Zhang, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Plos One|March 16, 2017
Spatial analysis improves the detection of early corneal nerve fiber loss in patients with recently diagnosed type 2 diabetesDan Ziegler, Karsten Winter, Alexander Strom, et al.
BMJ Open|February 4, 2022
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathyGidon J Bönhof, Gundega Sipola, Alexander Strom, et al.
Clinical Therapeutics|January 26, 2008
Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studiesDaniel K Kajdasz, Smriti Iyengar, Durisala Desaiah, et al.
Diabetes Care|July 22, 2011
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trialDan Ziegler, Phillip A Low, William J Litchy, et al.
Diabetes/Metabolism Research and Reviews|March 27, 2018
Myeloperoxidase, superoxide dismutase-3, cardiometabolic risk factors, and distal sensorimotor polyneuropathy: The KORA F4/FF4 studyChristian Herder, Julia M Kannenberg, Cornelia Huth, et al.
Diabetes/Metabolism Research and Reviews|July 4, 2024
Association of transketolase polymorphisms with diabetic polyneuropathy in the general population: The KORA F4 studyDan Ziegler, Barbara Thorand, Alexander Strom, et al.
The Journal of Clinical Endocrinology and Metabolism|March 29, 2020
Vitamin B12 and Folate Concentrations in Recent-onset Type 2 Diabetes and the Effect of Metformin TreatmentGeorgia Kanti, Evrim Anadol-Schmitz, Pavel Bobrov, et al.
Diabetes Care|December 8, 2018
General and Abdominal Obesity and Incident Distal Sensorimotor Polyneuropathy: Insights Into Inflammatory Biomarkers as Potential Mediators in the KORA F4/FF4 CohortSabrina Schlesinger, Christian Herder, Julia M Kannenberg, et al.
Diabetes, Obesity & Metabolism|June 16, 2025
Magnesium and thiamine supplementation increases renal mitochondrial respiration in lean C57BL/6J but not in obese ob/ob miceSebastian Sill, Fariba Zivehe, Carina Heitmann, et al.
Environmental Health Perspectives|December 28, 2020
Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 StudyChristian Herder, Alexandra Schneider, Siqi Zhang, et al.
Pageof 19